Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
diagnostics - search results
If you're not happy with the results, please do another search
Learning from COVID-19 and the continuing malaria fight
Michelle Davis, Head of External Relations at Malaria Consortium, shares with us what we need to know about learning from COVID-19 and the continuing fight against malaria.
Hospitals of the future: The importance of digital transformation skills
Here, Fraunhofer Germany discuss how COVID-19 has driven the adoption of digital health technologies, and offers solutions aiding healthcare professionals to keep up.
Animal health: African swine fever
African swine fever is placed under the spotlight here by Prof. Dr. José Manuel Sánchez-Vizcaíno, Full Professor of Animal Health at Universidad Complutense de Madrid.
PCR Biosystems: Scaling up the production of critical reagents in a crisis
Here, we interview Alex Wilson, Co-founder of specialist reagent company PCR Biosystems, discussing how their expertise in enzyme development and large-scale production has been successfully applied to COVID-19 testing solutions around the world.
Ground-breaking technology: Next generation sequencing
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, provides a portrait of a ground-breaking technology, next-generation sequencing, starting with a brief snapshot.
New technologies for knowledge translation in cancer
Ahmed Samir Abdelhafiz and Zisis Kozlakidis both shed light on new technologies for knowledge translation in cancer.
Global bioinformatics surveillance: SARS-CoV-2 variant detection tests
Shiao Yee, Marketing Communications Manager, Novacyt Group, discusses how global bioinformatics surveillance drives innovation in SARS-CoV-2 variant detection tests.
What happens now that the US supports the TRIPS waiver?
Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the new US stance could change the TRIPS waiver debate.
The importance of the life science sector to the post-COVID economic recovery
Dean Billington, Chief Operating Officer at Brains Bioceutical, discusses the pivotal role of the life science sector in spearheading the post-Covid economic recovery and why driving forward R&D and innovation should be the nation’s top priority.
COVID-19: The evolution of testing & sequencing
Novacyt Group, discusses the evolution of testing and sequencing during COVID-19 with a panel of distinguished speakers.
Plague: The first pandemic disease
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, writes in detail about plague, the first pandemic disease including comment on bacteria.
Horizon Europe: EU research & innovation
Mariya Gabriel, European Commissioner for Innovation, Research, Culture, Education and Youth, describes Horizon Europe and scaling up high-impact and breakthrough research & innovation.
How will everyone benefit if WTO members sign the TRIPS COVID-19 waiver?
Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the TRIPS COVID-19 waiver rejected by the WTO could ramp up global vaccine production.
COVID-19: The truth about super-spreaders
Dr Deborah Lee from Dr Fox Online Pharmacy, reveals the truth about super-spreaders as part of our focus on COVID-19.
Sustainable technology in the age of a pandemic
Lecturer and Interdisciplinary Researcher Chad Manian examines the progress of sustainable IT in the age of the COVID-19 pandemic, and discusses digital transformation as a means of crisis response.
DNA testing can rapidly identify pneumonia in COVID-19 patients
Researchers have developed a DNA test to rapidly identify pneumonia in COVID-19 patients, aiding faster treatment.
Jordan M Berg – Division of CMMI, U.S. NSF
Jordan M. Berg serves as a Program Officer in the Engineering Directorate of the US National Science Foundation.
Improving access to healthcare innovation: An international perspective
Dr Eugene Durenard, CEO of Hyperbolic Holdings GmbH, discusses the importance of improving access to healthcare innovation on an international scale.
Commissioner Mariya Gabriel on COVID-19 research and innovation in Europe
EU Commissioner Mariya Gabriel shares her ambitious policy plans on the coronavirus pandemic, especially in relation to research and innovation in Europe.
The future of treating gestational diabetes
Dr Lucy Mackillop, Chief Medical Officer, Sensyne Health discusses the future of treating gestational diabetes.
